We are pioneering immuno-neurology as a new way to potentially create medicines. Our immuno-neurology approach aims to target the innate immune system of the brain to counteract brain pathologies. Click below for more information.
Alector
Biotechnology Research
South San Francisco, California 17,014 followers
We are harnessing the immune system to treat neurodegeneration and cancer.
About us
We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.
- Website
-
http://alector.com
External link for Alector
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2013
- Specialties
- Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology
Locations
-
Primary
131 Oyster Point Blvd
Suite 600
South San Francisco, California 94080, US
Employees at Alector
Updates
-
Alexander Yang says he appreciates the "open dialogue and real time feedback that organically builds trust and collaboration" here at Alector. Learn more about this senior scientist, incredible manager and golf fanatic in this month's employee spotlight.
-
Alector is proud to sponsor Massachusetts General Hospital Frontotemporal Disorders Unit's hybrid community event in Boston this week. Hosted in Spanish, this event aims to bring information about FTD to the Hispanic community through a screening of the short film about a woman living with dementia and her daughter as her caregiver, followed by a live Q&A session with the filmmakers and an MGH Neurology Department clinician to raise awareness about young-onset #dementia, its impact on caregivers and brain health for all. Learn more and register for this in-person and live streamed event below. https://lnkd.in/eb2b_xnp
-
The Alzheimer's Foundation of America Educating America Tour is in full swing for 2024, and Alector continues to be a proud sponsor. We were glad to connect with members of the community in Louisville, KY at yesterday's event.
-
Members of the Alector team are in Denver for #AANAM this week! Thank you for another informative event on the latest #neurology news & insights, American Academy of Neurology.
-
Alector is proud to be one of the sponsors the Remember Me podcast, with incredibly moving episodes combining stories with science. Lauren Massimo, Co-Director of Penn Medicine, University of Pennsylvania Health System’s FTD Center, shared insight into apathy, one of the most common symptoms of #FTD, during Season 8. Listen in below.
-
We are excited to share that Neil Berkley has joined Alector as Chief Business Officer. Neil brings over 20 years of experience in corporate development, business development, and strategic planning from various biotech and pharma companies. He will be responsible for driving strategic growth and maximizing partnership opportunities at Alector. Welcome, Neil!
-
Congratulations to Alectorians Cameron Hagen and Jessica Sun for being named our February Value Champions! Their contributions and collaboration in their roles are integral to their teams. Thank you both for all you do.
-
Dementia and Alzheimer's are not interchangeable diagnoses. #Alzheimers disease makes up 60-80% of dementia cases. Knowing the signs and symptoms of all four types of #dementia can help you to recognize differences in a loved one and seek medical advice earlier.
-
Meet Melissa McClain, Director of Corporate & Internal Communications! Outside of work, Melissa spends most of her time watching her four kids under 8 years old play various sports. Learn more about Melissa and her role at Alector in this month's employee spotlight.